Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc. is a biopharmaceutical company that focuses on developing innovative therapies for neurological disorders. The company is known for its products, including AMPYRA (dalfampridine) and INBRIJA (levodopa inhalation powder), which are designed to improve the quality of life for individuals with conditions such as multiple sclerosis and Parkinson's disease. Recently, Acorda's products and its ARCUS technology have been acquired by Merz Therapeutics. Following this acquisition, these therapies will continue to be accessible to patients through Merz Therapeutics. Looking for business intelligence data on Acorda Therapeutics or other suppliers of Pharmaceuticals? Set up your free account with IndustrySelect.
Location Information
Contact Information
Product & Service Information
Map & Driving Directions
Supplier Notes
|
*This form will not be sent to Acorda Therapeutics, Inc. To contact Acorda Therapeutics, Inc. please call the number listed to the left.
|
|
Is this your business? Claim this listing for FREE to update your info, logo, & more! [Video]
Get found! Upgrade your listing to move up in the search results and receive buyer inquiries. |